Vaccine effectiveness and duration of protection against symptomatic infections and severe Covid-19 outcomes in adults aged 50 years and over, France, January to mid-December 2021.

Suarez Castillo, Milena; Khaoua, Hamid; Courtejoie, Noémie

Vaccine effectiveness and duration of protection against symptomatic infections and severe Covid-19 outcomes in adults aged 50 years and over, France, January to mid-December 2021.

Suarez Castillo, Milena; Khaoua, Hamid; Courtejoie, Noémie.

Afiliação

Suarez Castillo M; DREES, Statistics office of the French Ministry for Solidarity and Health, Paris, France.
Khaoua H; INSEE, National Institute of Statistics and Economic Studies, Montrouge, France.
Courtejoie N; DREES, Statistics office of the French Ministry for Solidarity and Health, Paris, France.

Glob Epidemiol ; 4: 100076, 2022 Dec.

Article em En | MEDLINE | ID: mdl-35662871

Palavras-chave

Booster; COVID-19; Effectiveness; Real-world estimates; SARS-CoV-2; Test-negative design; Vaccine

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article